Literature DB >> 34766940

Bimodal Hearing with Pediatric Cochlear Implant Recipients: Effect of Acoustic Bandwidth.

René H Gifford1, Linsey Sunderhaus1, Sterling Sheffield2.   

Abstract

OBJECTIVE: The primary purpose of this study was to examine the effect of acoustic bandwidth on bimodal benefit for speech understanding in pediatric cochlear implant (CI) recipients. STUDY
DESIGN: Ten children (6-13 years) with CIs utilizing a bimodal hearing configuration participated in this study. Speech understanding was assessed via recorded Pediatric AzBio sentences presented in a 10-talker babble. The CI stimulus was always unprocessed and the low-pass filtered acoustic stimuli were delivered to the non-CI ear with the following cutoff frequencies: 250, 500, 750, 1000, and 1500 Hz.
SETTING: Tertiary referral center. MAIN OUTCOME MEASURES: Sentence recognition in noise for the acoustic-alone, CI-alone, and bimodal listening conditions.
RESULTS: The primary findings were: (1) children gained significant bimodal benefit with 250 Hz, and (2) children demonstrated no statistically significant additional bimodal benefit with increasing acoustic bandwidth.
CONCLUSIONS: Acoustic bandwidth effects for pediatric CI recipients were significantly different than those documented in the literature for adult CI recipients. Specifically, this group of pediatric CI recipients demonstrated no increases in bimodal benefit with increases in acoustic bandwidth, primarily consistent with a segregation theory of bimodal integration.
Copyright © 2021, Otology & Neurotology, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34766940     DOI: 10.1097/MAO.0000000000003375

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Emotional Responses to Non-Speech Sounds for Hearing-aid and Bimodal Cochlear-Implant Listeners.

Authors:  Marina M Tawdrous; Kristen L D'Onofrio; René Gifford; Erin M Picou
Journal:  Trends Hear       Date:  2022 Jan-Dec       Impact factor: 3.496

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.